How is the Galecto Inc today?

The Galecto Inc today is trading in the green, up by 3.42% at 3.33.

How has Galecto Inc performed historically?

The Galecto Inc is currently trading up 3.42% on an intraday basis in the past week the index fell -1.77%. The index has been down -22.38% in the past quarter and rose 579.59% in the past year. You can view this in the overview section.

What is Galecto Inc Annual Net Profit?

Galecto Inc Annual Net Profit rose 44.1% in the last year to $21.44 M. Its sector's average net profit growth for the last fiscal year was -14.04%.

What is Galecto Inc Price to Earning Ratio?

Galecto Inc Price to Earning Ratio is -0.24, which is negative.

What is Galecto Inc Stock Price?

Galecto Inc Stock Price rose 579.59% and outperformed its sector by 152.5% in the past year.

What is Galecto Inc Quarterly Net profit?

Galecto Inc Quarterly Net profit rose 53.75% YoY to $2.53 M. Its sector's average net profit growth YoY for the quarter was -236.05%.

What is Galecto Inc Debt to Equity Ratio?

Galecto Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Galecto Inc Return on Equity(ROE)?

Galecto Inc Return on Equity(ROE) for the last financial year was -91.62%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Galecto Inc Mutual Fund Holding?

Galecto Inc Mutual Fund Holding increased by 0.04% in the last quarter to 2.45.

What is Galecto Inc Institutional Holding?

Galecto Inc Institutional Holding increased by 0.97% in the last quarter to 11.72.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
GALECTO INC

Galecto Inc XNAS: GLTO

Galecto Inc Live Share Price Today, Share Analysis and Chart

Name: Galecto Inc: Is Infosys Ltd. worth buying?
Item: Galecto Inc
Rating: 1.24308325
Author: Trendlyne DVM scores

about

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...

3.33 0.11 (3.42%)

77.53% Fall from 52W High

17,306

XNAS Volume

XNAS 18 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Galecto Inc is on 20 Jun 2025 for the purpose of Galecto Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

15.3 / 100

Technically Bearish

34.4 / 100

No estimates available

Galecto Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Galecto Inc Live Share Price Today, Share Analysis and Chart

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...

77.53% Fall from 52W High

SWOT Analysis

Galecto Inc Live Price Chart

Galecto Inc FAQ

How is Galecto Inc today?

Galecto Inc today is trading in the green, and is up by 3.42% at 3.33.

How has Galecto Inc performed historically?

Galecto Inc is currently trading up 3.42% on an intraday basis. In the past week the stock fell -1.77%. stock has been down -22.38% in the past quarter and rose 579.59% in the past year. You can view this in the overview section.